PER percheron therapeutics limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-8

  1. 14,770 Posts.
    lightbulb Created with Sketch. 1590
    I understand your frustration
    Nothing is set in stone when it’s regarding Biotech trials
    But
    ” we only get one shot. so we have to do it right”
    The only problem I see is the read out which could jeopardise the 48c options…due in late Dec 2024.
    but
    im sure if we are successful with Tox and the trial .. a Partner will step up $$


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.9¢
Change
0.000(0.00%)
Mkt cap ! $9.786M
Open High Low Value Volume
0.9¢ 0.9¢ 0.9¢ $5.617K 624.0K

Buyers (Bids)

No. Vol. Price($)
25 6950862 0.8¢
 

Sellers (Offers)

Price($) Vol. No.
0.9¢ 899422 1
View Market Depth
Last trade - 16.10pm 28/07/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.